The effect of Th2 cells in colorectal cancer is ambiguous; thus, elucidating the precise function of Th2 responses in colorectal cancer will facilitate the development and evaluation of novel cancer immunotherapeutics targeting SETD2 in Tregs. Here, SETD2 is linked to cancer.